Cheng Lian

Title: Cheng Lian: Innovator in RNA Virus Research

Introduction

Cheng Lian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of RNA virus research, particularly through his innovative patent that addresses critical aspects of viral detection and treatment.

Latest Patents

Cheng Lian holds a patent titled "Target sequence of RNA virus and use thereof." This invention provides a target sequence of an RNA virus, which is a nucleic acid sequence fragment containing 20-40 bases with at least 95% similarity to the genome sequence of humans or related species, such as livestock and poultry. The patent outlines a primer composition for constructing the target sequence, biomaterials like antisense RNA, and applications in vaccine design. The invention proposes that the target fragment is an important pathogenic substance of the RNA virus, with significant implications for the detection, diagnosis, and treatment of diseases caused by RNA viruses.

Career Highlights

Cheng Lian has worked with notable organizations, including the Shanghai Public Health Clinical Center and Shanghai Yizhe Biotechnology Co., Ltd. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Cheng has collaborated with esteemed colleagues, including Wenqiang Yu and Zhenyan Li. These partnerships have further enriched his research endeavors and have led to valuable insights in the field of RNA viruses.

Conclusion

Cheng Lian's innovative work in RNA virus research exemplifies the importance of scientific advancements in public health. His contributions through patents and collaborations continue to pave the way for future developments in the detection and treatment of viral diseases.